Kinnevik (KINV) Pre-silent presentation summary
Event summary combining transcript, slides, and related documents.
Pre-silent presentation summary
26 Jan, 2026Key milestones and portfolio developments
Investment activity remained steady, with a major undisclosed investment to be revealed with earnings.
Perk rebranded and achieved 48% revenue growth in 2025, reaching EUR 360m ARR and 76% gross margin.
Cityblock grew to USD 1.5bn ARR by end of 2025, up from USD 1bn in 2024, serving over 130,000 members in 10 states.
Enveda advanced its lead candidate to Phase 2a trials and now has three assets in the clinic, validating its discovery platform.
Vay secured investment from Grab at a premium to NAV, with a potential takeover path; Stegra financing round ongoing.
External valuation and market environment
Broad-based peer multiple compression and currency depreciation created 15–20% valuation headwinds in Q4 2025.
US Dollar and Euro both depreciated 2% against SEK, impacting 64% and 31% of the private portfolio, respectively.
Portfolio exposure includes tech-enabled VBC, healthcare technology, e-commerce logistics, and digital wealth managers.
Market benchmarks for core and mature companies showed significant declines, with some sectors down as much as 40%.
NAV and portfolio composition as of Q3 2025 reflect these market and currency shifts.
Latest events from Kinnevik
- NAV up 6% to SEK 29.6bn, with cost cuts, management changes, and strong portfolio growth.KINV
Q2 202615 Jul 2026 - NAV fell 8% to SEK 35.9bn as market headwinds offset robust core company growth.KINV
Q4 20258 Jul 2026 - New CEO appointed, portfolio companies excel, and SaaS valuations shift across subsectors.KINV
Pre-silent presentation22 Jun 2026 - NAV dropped 22% to SEK 27.9bn, net loss SEK 7,969m, with cost cuts and portfolio refocus underway.KINV
Q1 202616 Apr 2026 - AI-driven derating and macro uncertainty caused sharp valuation drops across key portfolio sectors.KINV
Pre-silent presentation7 Apr 2026 - NAV fell 4.7–5% as core growth companies outperformed and capital deployment set to rise.KINV
Q2 20243 Feb 2026 - NAV fell 5% to SEK 37.4bn as VillageMD was written down, but core assets grew over 60%.KINV
Q3 202419 Jan 2026 - Focused on high-growth private assets in health, software, and climate tech, targeting 15–25%+ returns.KINV
CMD 202419 Jan 2026 - NAV up 5% to SEK 39.2bn, core companies grew 55%, strong SEK 10.9bn net cash for growth.KINV
Q4 20249 Jan 2026